# EdiGene funding: rounds and investors > EdiGene has raised $87M across 3 rounds since 2018. Investors include Green Pine Capital, IDG Capital and HSG. Every round with its source. Source: https://millionrounds.com/company/edigene (Millionrounds; every figure on the page links to its filing or article) Japan · [Series B startup](https://millionrounds.com/companies) # Who invested in *EdiGene* 3 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$87M** raised across 3 rounds since 2018, from 4 sources **$15M** Series B **$10M** Series B **$62M** Series B - **Latest round:** Series B, $62M Apr 2021 - **Step-up i:** 6.2× - **Investors:** 14 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 **$15M** Series B **$10M** Series B **$62M** Series B - **First round:** Series B, $15M - **Biggest round:** $62M - **Usual gap between rounds:** 2.2 years ## The rounds - **Apr 2021** Series B **$62M** *4 new* *1 returning* [IDG Capital](https://millionrounds.com/fund/idg-capital) [HSG](https://millionrounds.com/fund/hsg) [Green Pine Capital](https://millionrounds.com/fund/green-pine-capital-partners) [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) [Sherpa Healthcare Partners](https://millionrounds.com/fund/sherpa-healthcare-partners) Source recorded - **Feb 2019** Series B **$10M** *1 new* [Green Pine Capital](https://millionrounds.com/fund/green-pine-capital-partners) Reported by Caixinglobal - **Aug 2018** Series B **$15M** *9 new* [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) [UTokyo Innovation Platform](https://millionrounds.com/fund/utokyo-innovation-platform) [IDG](https://millionrounds.com/fund/idg) [SBI](https://millionrounds.com/fund/sbi) [WI Harper](https://millionrounds.com/fund/wi-harper) [SMBC](https://millionrounds.com/fund/smbc) [FastTrack](https://millionrounds.com/fund/fasttrack) CareNet Group Lilly Asia Ventures/ Huagai Reported by FinSMEs and 1 other ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2018 **Series B** 2019 **Series B** 2021 [Green Pine Capital](https://millionrounds.com/fund/green-pine-capital-partners) [IDG Capital](https://millionrounds.com/fund/idg-capital) [HSG](https://millionrounds.com/fund/hsg) [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) [Sherpa Healthcare Partners](https://millionrounds.com/fund/sherpa-healthcare-partners) [UTokyo Innovation Platform](https://millionrounds.com/fund/utokyo-innovation-platform) [IDG](https://millionrounds.com/fund/idg) [SBI](https://millionrounds.com/fund/sbi) [WI Harper](https://millionrounds.com/fund/wi-harper) ## Everyone who backed them [Green Pine Capital](https://millionrounds.com/fund/green-pine-capital-partners) VC firm **2** rounds [IDG Capital](https://millionrounds.com/fund/idg-capital) Private equity **1** round [HSG](https://millionrounds.com/fund/hsg) VC firm **1** round [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) VC firm **1** round [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) VC firm **1** round [Sherpa Healthcare Partners](https://millionrounds.com/fund/sherpa-healthcare-partners) VC firm **1** round [UTokyo Innovation Platform](https://millionrounds.com/fund/utokyo-innovation-platform) Growth equity **1** round [IDG](https://millionrounds.com/fund/idg) VC firm **1** round [SBI](https://millionrounds.com/fund/sbi) Growth equity **1** round [WI Harper](https://millionrounds.com/fund/wi-harper) VC firm **1** round [SMBC](https://millionrounds.com/fund/smbc) VC firm **1** round [FastTrack](https://millionrounds.com/fund/fasttrack) Advisor **1** round CareNet Group no record of our own yet **1** round Lilly Asia Ventures/ Huagai no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=edigene). ## Also claim to have backed them These 2 firms list EdiGene as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [WI Harper Group](https://millionrounds.com/fund/wi-harper-group-2) VC firm Per its own site [Emerging Technology Partners](https://millionrounds.com/fund/emerging-technology-partners) VC firm Per its own site ## Quick answers about EdiGene ### Who invested in EdiGene? EdiGene's investors include Green Pine Capital, IDG Capital, HSG, Mizuho Capital and Lilly Asia Ventures, and 9 more on record. ### How much has EdiGene raised? EdiGene has raised $87M across 3 rounds since 2018. ### When did EdiGene last raise? EdiGene's most recent round was a Series B of $62M in Apr 2021. ### What was EdiGene's biggest round? Its most recent round, $62M in Apr 2021, is also its largest on record. ### Who backed EdiGene first? EdiGene's first round on record, in Aug 2018, was backed by Mizuho Capital, UTokyo Innovation Platform and IDG and 6 others. ### What stage is EdiGene at? EdiGene's latest named round is a Series B, in Apr 2021. ### Where is EdiGene based? EdiGene is based in Japan. ## Companies like EdiGene In the same sector, and raised in the last eighteen months. [**Kinish** $35M · Oct 2026](https://millionrounds.com/company/kinish)[**RadioNano Therapeutics** $955K · Oct 2026](https://millionrounds.com/company/radionano-therapeutics)[**AI Dock** $1.6M · Aug 2026](https://millionrounds.com/company/ai-dock)[**Dioseve** $12M · Jun 2026](https://millionrounds.com/company/dioseve)[**CareLink** $1.5M · Jun 2026](https://millionrounds.com/company/carelink)[**Neusignal Therapeutics** $40M · Jun 2026](https://millionrounds.com/company/neusignal-therapeutics) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app